-
1.
公开(公告)号:EP1860119A1
公开(公告)日:2007-11-28
申请号:EP06714335.4
申请日:2006-02-22
发明人: AKAHORI, Yasushi , SUGIOKA, Atsushi, VIEQU COURT DENJIYAMA , HAYASHI, Nobuhiro , TAKASAKI, Akihiko , SUZUKI, Kazuhiro , MORITA, Miwa , KUROSAWA, Yoshikazu , IBA, Yoshitaka , SUMITOMO, Mariko , TSUTSUMI, Susumu , OGAWA, Keiko , MATSUDA, Kazuki , MURAMATSU, Chiho , TAKAHASHI, Nobuhiro, c/ The Faculty of Agriculture , FUJIYAMA, Sari, c/o The Faculty of Agriculture , AZUMA, Masachika, c/o Inst. Antibodies Co., Ltd , UKAI, Yoshinori, c/o Inst. Antibodies Co., Ltd , MORISHITA, Kazuhiro, Miyazaki Medical College, Dept. of Biochemistry
IPC分类号: C07K16/28 , A61K39/00 , A61P35/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12Q1/02 , G01N33/15 , G01N33/50
CPC分类号: C07K16/303 , A61K2039/505 , C07K16/2803 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/732 , C07K2319/00 , G01N33/57426 , G01N33/57438
摘要: It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressen in lung cancer cells, with an antibody, and ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treatig cancer, etc.
摘要翻译: 旨在澄清可用作治疗或诊断癌症并在医学领域或研究领域中利用分子的靶标的分子。 通过用抗体处理被鉴定为在肺癌细胞中特异性表达的分子的IgSF4,并施加ADCC活性。 基于该发现,提供抗IgSF4抗体作为治疗癌症等方面的有效手段。
-
公开(公告)号:EP1860119B1
公开(公告)日:2011-08-03
申请号:EP06714335.4
申请日:2006-02-22
发明人: AKAHORI, Yasushi , SUGIOKA, Atsushi, VIEQU COURT DENJIYAMA , HAYASHI, Nobuhiro , TAKASAKI, Akihiko , SUZUKI, Kazuhiro , MORITA, Miwa , KUROSAWA, Yoshikazu , IBA, Yoshitaka , SUMITOMO, Mariko , TSUTSUMI, Susumu , OGAWA, Keiko , MATSUDA, Kazuki , MURAMATSU, Chiho , TAKAHASHI, Nobuhiro, c/o The Faculty of Agriculture , FUJIYAMA, Sari , AZUMA, Masachika, c/o Inst. Antibodies Co., Ltd , UKAI, Yoshinori, c/o Inst. Antibodies Co., Ltd , MORISHITA, Kazuhiro, Miyazaki Medical College, Dept. of Biochemistry
IPC分类号: C07K16/28 , A61K39/00 , A61P35/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12Q1/02 , G01N33/15 , G01N33/50
CPC分类号: C07K16/303 , A61K2039/505 , C07K16/2803 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/732 , C07K2319/00 , G01N33/57426 , G01N33/57438
摘要: It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, an ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.
-
3.
公开(公告)号:EP2078732A1
公开(公告)日:2009-07-15
申请号:EP07790510.7
申请日:2007-07-09
发明人: SUGIOKA, Atsushi , SUGIURA, Mototaka , AKAHORI, Yasushi , HAYASHI, Nobuhiro , TAKASAKI, Akihiko , MORITA, Miwa , KUROSAWA, Gene , SUMITOMO, Mariko , TSUTSUMI, Susumu , OGAWA, Keiko , MATSUDA, Kazuki , MURAMATSU, Chiho , SATOU, Noriko , AZUMA, Masachika , UKAI, Yoshinori , SUZUKI, Kazuhiro , KUROSAWA, Yoshikazu , TANAKA, Miho , SHIRAISHI, Mamoru
IPC分类号: C07K16/28 , C12N15/09 , C12Q1/02 , G01N33/574
CPC分类号: C07K16/30 , C07K16/005 , C07K16/28 , C07K16/2803 , C07K16/2863 , C07K16/2896 , C07K16/303 , C07K16/32 , C07K16/40 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/732 , C12N15/1138 , C12N2310/14 , G01N33/57492 , G01N33/6854
摘要: It is intended to provide a method whereby a plural number of antibodies against cell surface antigens are quickly classified and to provide a method whereby antigens of the thus classified antibodies are quickly identified. Further, it is intended to provide a method of promoting the utilization of the useful data obtained by the above methods. Furthermore, it is intended to provide an antibody which is effective in treating or diagnosing cancer. Namely, a method of classifying antibodies which comprises: (1) the step of preparing a plural number of antibodies respectively recognizing cell surface antigens; (2) the step of bringing each of these antibodies into contact with a cell of the same species; (3) the step of analyzing each of the cells having been treated in the step (2) by flow cytometry and thus obtaining data indicating the reactivity of each antibody with its cell surface antigen; and (4) the step of comparing the thus obtained data and classifying the individual antibodies depending on the similarity. A method of identifying antigens which further comprises: (5) the step of selecting one to several antibodies from each antibody group formed in the step (4) and identifying antigens thereof; and (6) on the assumption that antigens of the antibodies belonging to a single antibody group are the same or highly related to one another, making relations between the antigens having been identified in the step (5) and the antibody groups to thereby identify the antigens. An antibody against HER1, an antibody against HER2, an antibody against CD46, an antibody against ITGA3, an antibody against ICAM1, an antibody against ALCAM, an antibody against CD147, an antibody against C1qR, an antibody against CD44, an antibody against CD73, an antibody against EpCAM and an antibody against HGFR, each obtained by using the above methods.
摘要翻译: 它的目的是提供其中针对细胞表面抗原的抗体有多个被分类快速,是提供一种方法,由此将这样分类的抗体的抗原迅速识别的方法。 此外,它的目的是提供电视节目预告亭的方法通过上述方法获得的有用数据的利用。 进一步,它的目的是提供所有这是有效治疗或诊断癌症的抗体。 即,分类的抗体的方法,其包括:(1)制备抗体的分别认识细胞表面抗原的复数数的步骤; (2)使每个合成抗体与相同物种的细胞接触的步骤; (3)分析每个细胞的步骤中被处理,在步骤(2)通过流式细胞术和由此获得数据指示与它的细胞表面抗原,每种抗体的反应性; 和(4)比较由此获得的数据,并且根据该相似性的单个抗体分类的步骤。 识别抗原,另外还包括如下步骤:(5)选择一个,以从在步骤(4)以及它们的抗原识别形成的每个抗体组几种抗体的步骤; 和(6)在假设没有属于单个抗体组抗体的抗原相同或高度彼此相关,使得抗原之间的关系,在步骤已被鉴定(5)和抗体组,从而识别所述 抗原。 对HER1的抗体,以针对HER2抗体,对抗CD46抗体关于对ITGA3抗体抗ICAM-1抗体对ALCAM抗体针对CD147的抗体,对抗C1qR抗体对抗CD44抗体关于对CD73抗体, 针对EpCAM的并针对HGFR抗体抗体,每个通过使用上述方法获得的。
-
-